Skip to main content
. 2016 Jul 12;2016:2989086. doi: 10.1155/2016/2989086

Table 2.

Fellow eye characteristics in patients with MTM surgery.

Group 1 (n = 38) Group 2 (n = 42) Group 3 (n = 10) Group 4 (n = 5) P value
Age, years 63.26 ± 8.29 61.40 ± 6.91 62.50 ± 6.52 66.00 ± 10.93 0.664a

Sex (male/female) 8/30 7/35 2/8 1/4 0.970b

Refraction, D −10.21 ± 6.15 −13.89 ± 4.50 −14.63 ± 3.74 −14.00 ± 4.74 0.015a

Axial length, mm 28.21 ± 2.78 29.53 ± 1.99 30.20 ± 1.24 30.04 ± 2.41 0.016a

Follow-up, months 22.55 ± 17.54 23.12 ± 14.32 34.80 ± 20.86 34.60 ± 17.16 0.138a

Poststaphyloma, number
 Yes 20 34 10 4 0.004b
 No 18 8 0 1

Chorioretinal atrophy
 Yes 7 19 9 4 <0.001b
 No 31 23 1 1

OCT change, number
 Improved 0 4 3 0 0.005b#
 Stable 34 28 1 2
 Worse 4 10 6 3

BCVA
 Baseline 0.10 0.40 1.0 0.9 <0.001a
 Final 0.20 0.45 1.0 0.9 <0.001a

RS, dB (final) 10.24 ± 4.10 8.83 ± 4.53 4.87 ± 4.03 5.79 ± 6.02 0.003a

aKruskal-Wallis test. bFisher's exact test. #compared with Groups 2, 3, and 4. Median.

BCVA: best-corrected visual acuity. RS: retinal sensitivity.